Morphological and Functional Changes in the Retina after Chronic Oxygen-Induced Retinopathy by Nakamura, Shinsuke et al.
Morphological and Functional Changes in the Retina
after Chronic Oxygen-Induced Retinopathy
Shinsuke Nakamura, Shunsuke Imai, Hiromi Ogishima, Kazuhiro Tsuruma, Masamitsu Shimazawa,
Hideaki Hara*
Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan
Abstract
The mouse model of oxygen-induced retinopathy (OIR) has been widely used for studies of retinopathy of prematurity
(ROP). This disorder, characterized by abnormal vascularization of the retina, tends to occur in low birth weight neonates
after exposure to high supplemental oxygen. Currently, the incidence of ROP is increasing because of increased survival of
these infants due to medical progress. However, little is known about changes in the chronic phase after ROP. Therefore, in
this study, we examined morphological and functional changes in the retina using a chronic OIR model. Both the a- and b-
waves in the OIR model recovered in a time-dependent manner at 4 weeks (w), 6 w, and 8 w, but the oscillatory potential
(OP) amplitudes remained depressed following a return to normoxic conditions. Furthermore, decrease in the thicknesses of
the inner plexiform layer (IPL) and inner nuclear layer (INL) at postnatal day (P) 17, 4 w, and 8 w and hyperpermeability of
blood vessels were observed in conjunction with the decrease in the expression of claudin-5 and occludin at 8 w. The
chronic OIR model revealed the following: (1) a decrease in OP amplitudes, (2) morphological abnormalities in the retinal
cells (limited to the IPL and INL) and blood vessels, and (3) an increase in retinal vascular permeability via the impairment of
the tight junction proteins. These findings suggest that the experimental animal model used in this study is suitable for
elucidating the pathogenesis of ROP and may lead to the development of potential therapeutic agents for ROP treatment.
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Introduction
Retinopathy of prematurity (ROP) is a disease that affects the
retinas of premature infants. The key pathological change,
namely, retinal neovascularization, is associated with local
ischemia followed by the subsequent development of neovascu-
larization. In the more severe forms of the disease, the abnormal
vascular changes may progress to retinal detachment. Once retinal
detachment occurs, the prognosis for recovery of good visual
acuity is poor. As a result, ROP is the leading cause of preventable
childhood retinal dysfunction. The World Health Organization’s
Vision 2020 programme targets ROP as an avoidable disease
requiring early detection and treatment to prevent blindness [1].
The severity of ROP is graded in stages from 1 to 5. Blindness
from ROP is caused by retinal detachment due to tractional retinal
angiogenesis (stage 5). Recently, it was reported that even mild
ROP (stages 1 or 2) can cause permanent functional sequelae
[2,3]. Rod-mediated abnormalities are involved in the regulation
of eye growth in children with mild ROP [2]. However, little is
known about the causes of the blindness that occurs in the absence
of retinal detachment. Further research is required to elucidate the
underlying causes of ROP, clarify the chronic functional and
morphological changes, and propose new prevention strategies.
The oxygen-induced retinopathy (OIR) model is widely used for
studies of retinal neovascular diseases such as ROP and diabetic
retinopathy [4,5]. The OIR model mirrors events that occur
during ROP, including the pathological alterations that affect
premature infants. At postnatal day (P) 18, ROP model rats show
significant abnormalities in both the retinal vasculature and neural
function [6]. Dysfunction of the neural retina, including
photoreceptors and post-receptors, has been documented in
patients with ROP and in the rat model [3,7,8,9]. However, it is
unclear why retinal function fails to return to normal even after the
disappearance of abnormal neovascular tufts.
The blood-retinal barrier (BRB) is a selective barrier of the eye
and is composed of capillary blood vessels. The BRB plays an
essential role in protecting the neural tissues from toxic materials
and maintaining the visual and neural functions of the retina. BRB
breakdown is one of the most important pathophysiological
changes in ischemic retinal diseases such as ROP and diabetic
retinopathy [10,11,12]. In fact, retinal vascular permeability is
higher in the rat OIR model than in normal rats; this occurs as a
result of increased production of vascular endothelial growth
factor (VEGF) [13]. Furthermore, degeneration of astrocytes has
been reported to be involved in the failure of the BRB in the feline
OIR model [14]. In developing mouse retinas, astrocytes trigger
postnatal onset of radial vascular extension from the optic disc by
secreting VEGF and depositing extracellular matrix scaffolds to
which the migrating endothelial cells adhere [15,16]. The barrier
properties of blood vessels are attributed mainly to the presence of
complex tight junction networks between endothelial cells [17].
Integral membrane proteins such as occludin [18], claudin
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are localized at tight junctions.
To create an effective therapeutic strategy for avoiding the
blindness caused by ROP, it is essential to understand the
relationship between retinal dysfunction and structure degenera-
tion. Although there is evidence that abnormalities occur in both
the retinal blood vessels and retinal cells in ROP [7,13,23], it is
unknown how neuronal and vascular abnormalities are chronically
related.
The purpose of the present study is to elucidate the interaction




To determine visual function after exposure to high oxygen, we
performed ERG analyses. Similar to previous reports [24,25,26],
OP1 was not analyzed because OP1 was contaminated by the a-
wave. The peak-to-trough amplitudes of the individual OP
wavelets (OP2, OP3, OP4, and OP5) were measured individually
from stimulus onset to peak. To examine retinal function, we
measured the amplitudes of the a- and b-waves. Both a- and b-
wave amplitudes were significantly decreased in the OIR model
mice at 4 w (Figs. 1A–C). However, in OIR model mice, we
observed a time-dependent recovery of the decrease in the a- and
b-wave amplitudes (Fig. 1–C). The OP amplitudes measured
under scotopic conditions in response to a flash are shown in
figure 2. For all OPs except OP2 at 8 w, the amplitudes for the
OIR model mice at 4, 6, and 8 w were approximately 50% less
than those in normal mice (Fig. 2).
Retinal damage
To investigate the damage in each retinal layer after exposure to
high levels of oxygen during infancy, we evaluated the number of
cells in the the ganglion cell layer (GCL) and the thicknesses of the
inner plexiform layer (IPL), inner nuclear layer (INL), outer
plexiform layer (OPL), and outer nuclear layer (ONL). In the OIR
mouse model retinas, the thicknesses of the IPL, OPL, and INL
decreased compared to those in normal mouse retinas at 4 and 8 w
(Figs. 3A, C–E). However, there were no significant differences in
the number of cells in the GCL and the thickness of the ONL
between the OIR model and normal mice (Figs. 3A, B, F).
Morphology of retinal blood vessels
We also examined retinal blood vessel morphology in OIR
mice. As shown in Figure 4, retinal flat-mounts visualized by
fluorescence angiography revealed significant abnormalities in
the retinal blood vessels of OIR mice. To quantify retinal
vascular development, we evaluated 4 parameters of retinal blood
vessel formation using imaging software: length, area, branch
points, and segments. At P17, abnormal vascular growth
occurred in the OIR model mice but not in normal mice
(Fig. 4A). Moreover, we found that the formation of retinal
microvasculature significantly decreased with respect to length,
branch points, and segment parameters in OIR model mice at
P17, 4 w, and 8 w (Figs. 4B, D, E). Vessel area showed a
decreasing tendency at 4 w, and we detected significant
differences at P17 and 8 w (Fig. 4C). Furthermore, we
investigated the change in retinal neovascularization between
the OIR model and normal mice. As previously reported [27],
the retinal neovascular tufts in the OIR model mice eventually
disappeared after peaking at P17 (Figs. 4F, G).
Permeability of retinal blood vessels
The permeability of retinal blood vessels was evaluated by
tracer experiments using FITC-dextran (2000 kDa) conjugated
with Hoechst 33342 (616 Da). This tracer has previously been
used to successfully evaluate the permeability of tight junctions of
epithelial cells [20,28,29]. Injected FITC-dextran was detected in
the vascular lumen. In addition, extravasation of Hoechst 33342
dye appeared as nuclear staining of surrounding retinal glial and
neural cells, and the degree of staining was enhanced in the OIR
model mice at 8 w (chronic phase) compared to that in normal
mice (Figs. 5A–D). Quantitative analysis showed that the retinal
permeability rate was significantly greater in the OIR model mice
at 8 w (Fig. 5F). Moreover, western blot analysis confirmed
significant decreases in both claudin-5 and occludin expression in
the retina of the OIR model mice (Figs. 5G, H).
Discussion
The main results of the present ROP study can be summarized
as follows: (1) there were deficits in OPs, which are useful indices of
IPL dysfunction; (2) retinal damage was found primarily in both
the IPL and INL where many retinal blood vessels exist; (3) retinal
vascular permeability increased via breakdown of the barrier
properties in retinal blood vessels. These findings indicate that
retinal hyperpermeability can cause retinal dysfunction and that
the murine chronic OIR model is suitable for evaluating the
pathogenesis of BRB disruption. Furthermore, these results
demonstrate that the present model is useful as a chronic OIR
model to clarify the relationship between visual function and
retinal vasculature.
In this study, ERG readings reflected the loss of retinal function.
To assess the retinal function in normal and OIR mice, the
amplitudes of a- and b-waves were measured as they are indicative
of photoreceptor function and the functional integrity of the INL,
respectively [30,31,32,33,34,35]. The cellular origin of OPs is
thought to be primarily amacrine cells, although ganglion and
bipolar cells may contribute to some parts of the OPs
[35,36,37,38]. In fact, OPs are helpful for identifying the
progression of diabetic retinopathy. In the present study, there
was a significant decrease in the amplitude of both a- and b-waves
in the OIR mice compared to those in normal mice at 4 w
(Figs. 1A, B). However, at 8 w (the chronic phase), there were no
alterations in the amplitudes of either the a- or b-waves (Figs. 1A,
B). Thus, transmission from photoreceptors may be impaired in
the chronic OIR model. On the other hand, the present results
revealed a uniform reduction in all OPs (Fig. 2). It has been
reported that both a- and b-wave amplitudes were significantly
decreased in the OIR rat at P30 and P60 [7]. Moreover, a
previous study reported that the OP amplitudes were smaller in
the OIR rat than in the normal rat at P67 [6]. In the chronic
phase, although the recovery of both a- and b-wave amplitudes in
the OIR mice was different from that in the rat OIR model, the
decrease in the OP-wave amplitudes in the murine OIR model
was in agreement with previous findings in the rat OIR model. As
recently reported by Recchia et al., there were changes in 43 genes
in each species, with 2 being common at an early time point (P13
in mice and P15 in rat) [39]. On the other hand, at a later time
point (P18 in mice and P20 in rat), there were changes in 26 genes
in the rat and 1622 in the mouse, with only 13 being common
[39]. Although it is not clear how these gene changes affect retinal
function, the differences in gene expression in both models may be
partly involved in retinal function.
In addition to compromised ERGs, we observed significant
decreases in the thicknesses of the IPL and INL in the OIR mice
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wave amplitudes (Figs. 1 and 3). Our finding that the reduction
in a- and b-wave amplitudes does not correspond with structural
degeneration concurs with the finding of a previous report [40].
The cellular origin of OPs is amacrine cells [41], which
constitute 40% of all cells in the INL [42]. In addition, VEGF
receptor activation results in the death of amacrine cell
progenitors [43]. Therefore, thinning of both the INL and IPL
may be related to retinal amacrine cell lesions in chronic OIR
mice. The formation of capillary beds in the outer retina as far as
the outer border of the INL occurs via budding from primary
blood vessels [44]. Because there were lesions in both the INL
and IPL, where retinal blood vessels are abundant, we examined
in detail whether the OIR mice exhibited evident vascular
pathology in the chronic phase. At 8 w, the OIR mice had no
neovascular tufts but showed decrease in blood vessel length,
area, branch points, and segments. These results indicate that
decreased capillary density occurs in OIR mice. The decrease in
capillary density might have an effect on retinal function, which
is reflected in OP amplitudes. The murine OIR model is not
identical to ROP in patients with respect to the angiogenic
mechanisms, including vasoobliteration. However, the present
study indicates that the murine OIR model is acceptable as an
animal model because we investigated the interaction of the
structural transition and retinal function in the chronic phase
when the vasoobliteration had disappeared.
Figure 1. Measurement of dark-adapted electroretinography (ERG) amplitudes in the oxygen-induced retinopathy (OIR) model and
normal mice. Amplitudes of a- (A) and b-waves (B) from the OIR model or from normal mice were measured at 4, 6, and 8 w. Stimulus flashes were
used from 22.92 to 0.98 log cds/m
2. (C) Representative ERG waveforms at 4, 6, and 8 w. Values are expressed as the mean 6 S.D., n=4 to 6.
*P,0.05,
**P,0.01 versus Normal. OIR, oxygen-induced retinopathy model.
doi:10.1371/journal.pone.0032167.g001
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mice, we evaluated both retinal permeability and expression of
retinal microvascular tight junction molecules. We found that
retinal hyperpermeability was observed with BRB disruption in
chronic OIR mice, and we evaluated claudin-5 and occludin
expression, which are involved in the assembly of tight junctions
between neural microvascular endothelial cells [18,20,21,28]. In
the retinas from the chronic murine OIR model, the expression of
both claudin-5 and occludin decreased. Because OPs are related to
ocular pathology or abnormalities [45,46,47], OP attenuation in
OIR mice might affect retinal hyperpermeability by decreasing
both claudin-5 and occludin in the chronic phase. The present
study is the first to show the importance of retinal permeability in
retinal dysfunction. Recently, it was shown that OP-waves are
markedly decreased in the region where retinal permeability was
increased in patients with diabetes and clinically significant
macular edema, as revealed by multifocal ERG [48]. The present
data correlated with data of the previous report with respect to the
relationship between OP-waves and retinal permeability.
In conclusion, these findings in the murine chronic OIR model
indicate that deficits in OPs may be a sign of BRB disruption,
which may be indicative of the early symptoms of retinal vascular
abnormalities. The chronic OIR model revealed vascular
impairment dysfunction without neovascular tufts; therefore, it
may be appropriate to investigate the pathogenesis of ROP that
leads to blindness caused by neovascularization without retinal
detachment. The abnormalities of the OPs seen on ERG can be
used to diagnose BRB disruption, and appropriate treatments,
such as protection of endothelial cells in the early phase, may be
able to prevent the loss of vision observed in ROP.
Materials and Methods
Animals
The experimental designs and all procedures were approved by
the Animal Experimental Committee of Gifu Pharmaceutical
University (permission number; 2009-206, 2010-037). All exper-
iments were performed in accordance with the ARVO Statement
for the Use of Animals in Ophthalmic and Vision Research, and
monitored by the Institutional Animal Care and Use Committee
of Gifu Pharmaceutical University. C57BL/6 mice (SLC,
Shizuoka, Japan) were used in this study. The mice were kept
under controlled lighting conditions (12:12-h light/dark).
OIR model
The OIR mouse model was created as described previously
[49]. In brief, P7 pups along with nursing mothers were placed in
75% oxygen. Pups were removed on P12, and oxygen was
continuously monitored with an oxygen controller (PRO-OX 110;
Reming Bioinstruments Co., Redfield, SD, USA). On P12, the
mice were returned to room air until P17, 4 weeks (4 w), or 8 w.
Control mice were reared in room air. For morphological analysis,
eyes were enucleated at P17, 4 w, and 8 w in both normal and
OIR model mice.
Electroretinography
ERG measurements in mice were performed as described in our
previous report [50]. Electroretinograms (ERGs) were recorded 5
days after light exposure (Mayo, Aichi, Japan). Mice were
maintained in a completely dark room for 24 h before being,
intraperitoneally anesthetized with a mixture of ketamine
(120 mg/kg) (Daiichi-Sankyo, Tokyo, Japan) and xylazine
(6 mg/kg) (Bayer Health Care, Tokyo, Japan). The pupils were
dilated with 1% tropicamide and 2.5% phenylephrine (Santen,
Osaka, Japan). Flash ERG was recorded in the left eyes of the
dark-adapted mice by placing a golden-ring electrode (Mayo) in
contact with the cornea and a reference electrode (Nihon Kohden,
Tokyo, Japan) through the tongue. A neutral electrode (Nihon
Kohden) was inserted subcutaneously near the tail. All procedures
were performed in dim red light, and the mice were kept warm
during the entire procedure; body temperature was maintained
with a heating pad. All animals recovered from anesthesia after the
ERG recording sessions.
To demonstrate the oscillatory potentials (OPs), the OP
amplitudes were measured in the time between the a- and b-
wave peaks; the factors were OP number (OP2, OP3, OP4, and
OP5), age (4, 6 and 8 w), and flash intensity [0.98 (log cds/m
2)].
According to a previous report [51], the first OP wave is
contaminated by the a-wave. Therefore, the first OP waves were
not analyzed. The amplitude of the a-wave was measured from the
baseline to the maximum a-wave peak, and the b-wave was
measured from the maximum a-wave peak to the maximum b-
wave peak according to age (4, 6, 8 w) and flash intensity [22.92–
0.98 (log cds/m
2)]. In the present study, OPs amplitudes were
measured by using ERG with all frequency (0.3–500 Hz).
Figure 2. The oscillatory potentials (OPs) amplitudes in
response to a light flash in the oxygen-induced retinopathy
(OIR) model and normal mice. The averaged OP amplitudes were
measured at 4, 6, and 8 w. Values are expressed as the mean 6 S.D.,
n=4 to 6.
*P,0.05,
**P,0.01 versus Normal. OIR, oxygen-induced
retinopathy model.
doi:10.1371/journal.pone.0032167.g002
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PLoS ONE | www.plosone.org 4 February 2012 | Volume 7 | Issue 2 | e32167Figure 3. Retinal damage in the oxygen-induced retinopathy (OIR) model and normal mice. Retinal cross sections were prepared at 4 w and 8
w. (A) Hematoxylin and eosin staining. Scale bar, 50 mm. Retinal damage was evaluated by counting the number of cells in the GCL (B) and measuring
the thickness of the IPL (C), INL (D), and ONL (E) in mice at 4 w and 8 w. Values are expressed as the mean 6 S.D., n=5 or 6.
*P,0.05,
**P,0.01 versus
Normal. GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; ONL, outer nuclear layer; OIR, oxygen-induced retinopathy model.
doi:10.1371/journal.pone.0032167.g003
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PLoS ONE | www.plosone.org 5 February 2012 | Volume 7 | Issue 2 | e32167Figure 4. The development of retinal vascular lumen in the oxygen-induced retinopathy (OIR) model and normal mice. (A) Flat-
mounted retinas in the OIR model mice and normal mice, along with (insets) enlargements, at 3 time points (P17, 4 w, and 8 w). Scale bars, 500 mm
(100 mm in insets). Quantitative analysis of retinal vascular lumen at 4 w and 8 w was performed using an imaging analyzer (the Angiogenesis Tube
Formation module) on the entire retina; 4 parameters were measured: (B) length, (C) area, (D) branch points, and (E) segments. Values are expressed
as the mean 6 S.D., n=4 or 5.
**P,0.01 versus normal. OIR, oxygen-induced retinopathy model.
doi:10.1371/journal.pone.0032167.g004
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PLoS ONE | www.plosone.org 6 February 2012 | Volume 7 | Issue 2 | e32167Figure 5. Retinal permeability in the oxygen-induced retinopathy (OIR) model and normal mice. Each upper image is shown using
Metamorph (A, B). Confocal fluorescence micrographs (C, D) show a higher magnification version of part of the corresponding upper image. Scale
bars, 100 mm (B) and 50 mm (D). Retinal permeability was evaluated in the 4 areas shown in (E) (each area 0.144 mm
264 areas; total area 0.576 mm
2)
at 8 w. (F) Retinal permeability rate was quantified using mathematical formulae; see Materials and Methods for further details. Western immunoblots
of claudin-5 (G), occludin (H), and b-actin proteins in the retina at 8 w in the OIR model mice and in normal mice. Expression was quantified by
densitometry and corrected by reference to b-actin. Values are expressed as the mean 6 S.D., n=7 or 8.
**P,0.01 versus normal.
doi:10.1371/journal.pone.0032167.g005
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In mice under anesthesia (80 mg/kg sodium pentobarbital,
intraperitoneal), each eye was enucleated and kept immersed for at
least 24 h at 4uC in a fixative solution containing 4%
paraformaldehyde. Six paraffin-embedded sections (thickness,
5 mm) cut through the optic disc of each eye were prepared in a
standard manner and stained with hematoxylin and eosin. The
damage in OIR model mice was then evaluated with 3 sections
from each eye used for the morphometric analysis as described
below. Light microscope images were photographed using a digital
camera (COOLPIX 4500; Nikon, Tokyo, Japan). The cells in
GCL and the thicknesses of the IPL, INL, and ONL at a distance
between 375 and 625 mm from the optic disc were measured on
the photographs in a masked fashion by a single observer (H.O.).
Data 3 sections (randomly selected from the 6 sections) were
averaged for each eye and used to evaluate the cell count in the
GCL and the thickness of the IPL, the INL, and the ONL.
Imaging and quantification for retinal tube formation
Mice were sacrificed on P17 and perfused via the left ventricle
with 1 mL of 20 mg/mL fluorescein isothiocianate (FITC)-
dextran (Sigma–Aldrich, St. Louis, MO, USA) dissolved in PBS.
Eyes were enucleated and fixed for 1–6 h in 4% paraformalde-
hyde, and retinal flat-mounts were prepared. Total images of flat-
mounted retinas were produced via Metamorph (Universal
Imaging Corp., Downingtown, PA, USA). To evaluate the retinal
vascular lumen, we used the Angiogenesis Tube Formation
module. Tube length, area, branch points, and segments were
quantified from these images. We evaluated the number of nodes
and the node area, which is the region containing connected blobs
with a thickness exceeding the maximum width of the vessels; this
represents an area where there is pooling of fluorescein-conjugated
dextran.
Retinal permeability
The permeability of mouse retinal vessels was determined as
described previously [20,28]. Briefly, under deep anesthesia with
pentobarbital sodium, the mouse chest cavity was opened and was
inserted into the left ventricle. Each mouse was perfused with
1 mL of PBS containing 100 mg/ml Hoechst 33342 (molecular
mass, 616 Da; Sigma) and 20 mg/ml FITC-dextran (molecular
mass, 2000 kDa). The isolated retinas were flat mounted and
observed by a confocal microscopy (FluoView FV10; Olympus,
Tokyo, Japan). Moreover, to quantify retinal permeability using
Metamorph, fluorescent images were photographed (2006,
0.144 mm
2) using an epifluorescence microscope (BX50; Olym-
pus) fitted with a CCD camera (DP30VW; Olympus). Hoechst
33342 that did not merge with FITC-dextran at a distance of
1 mm from the optic disc were evaluated on the photographs in a
masked fashion by a single observer (S.N.). Data from the 4 parts
of each eye were used (total area, 0.576 mm
2). The following
equation was used to calculate retinal permeability rate:
Permeability rate~
Hoechst 33342 area{co localization area of FITC  ð
dextran and Hoechst 33342Þ= FITC dextran area ðÞ
Western blot analysis
In vivo, both normal mice and OIR model mice were euthanized
at 8 w using 80 mg/kg sodium pentobarbital intraperitoneally,
and their eyeballs were removed quickly. The retinas were
carefully separated from the eyeballs and quickly frozen in dry ice.
For protein extraction, the tissue was homogenized in cell lysis
buffer using a Physcotron homogenizer (Microtec Co. Ltd., Chiba,
Japan). The lysate was centrifuged at 12,0006g for 20 min, and
the supernatant used for this study. The protein concentrations
were measured by comparison with a known concentration of
bovine serum albumin using a bicinchoninic acid protein assay kit
(Pierce Chemical, Rockford, IL, USA). A mixture of equal parts of
an aliquot of protein and sample buffer with 10% 2-mercapto-
ethanol was subjected to 5%–20% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis. The separated protein was
then transferred onto a polyvinylidene difluoride membrane
(Immobilon-P; Millipore Billerica, MA, USA). For immunoblot-
ting, the following primary antibodies were used: claudin-5 mouse
monoclonal antibody (Invitrogen, CA, USA) (1:1000), occludin
rabbit polyclonal antibody (Santa Cruz Biotechnology, CA, USA)
(1:200) and b-actin mouse monoclonal antibody (Sigma-Aldrich)
(1:4000). Either goat anti-rabbit or anti-mouse horseradish
peroxidase-conjugated (1:2000) was used as a secondary antibody.
The immunoreactive bands were visualized using Super SignalH
West Femto Maximum Sensitivity Substrate (Thermo Fisher
Scientific K.K., Waltham, MA, USA), and measured using FLA-
2000 (Fujifilm, Tokyo, Japan).
Statistical analyses
Data are presented as the means 6standard error of the mean
(S.E.M). The control mice participated in all experiments, and
some OIR mice were used in multiple experiments. Statistical
comparisons were made using Student’s t-test [using StatView
version 5.0 (SAS Institute, Cary, NC, USA)]. A P value of ,0.05
was considered statistically.
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